100s of titles, one news app for just $10 a month.
Dive Deeper:
Get all your news in one place
Latest Business news:
HSBC suspends head of responsible investing who called climate warnings ‘shrill’
Bank investigating Stuart Kirk’s conference speech deriding flooding risks and climate warnings from UN and Bank of England
Read news from The Economist, FT, Bloomberg and more, with one subscription
Learn More
John O'Neill to front Star casino inquiry
Star Entertainment Group executive chairman John O'Neill is scheduled to appear at the gaming inquiry into its suitability to operate…
After $5 Trillion Rout, Emerging Markets Seek Turnaround Signal
The wreckage of a $5 trillion rout in emerging markets is starting to look like a buying opportunity to some…
New Zealand PM Ardern to visit U.S. to boost exports, lure tourists
New Zealand Prime Minister Jacinda Ardern will visit the United States this week in a bid to boost exports and…
Rod Sims says Facebook should be forced to negotiate with SBS under news media bargaining code
Despite dozens of deals to pay Australian news publishers for content, social media company has left out SBS and the…
From analysis to good news, read the world’s best news in one place
Crypto might have an insider trading problem
Anonymous wallets buy up tokens right before they are listed and sell shortly afterward
Airbus Sees Business Jet Sales Boost Despite War, China Lockdown
Airbus SE’s corporate-jet division is more optimistic about prospects for this year, even as the Russia-Ukraine conflict and Chinese coronavirus…

Earnings Preview: Novavax

By Benzinga Insights

Novavax (NASDAQ:NVAX) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement.

Analysts estimate that Novavax will report an earnings per share (EPS) of $2.69.

Novavax bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company missed EPS by $9.38, which was followed by a 0.44% increase in the share price the next day.

Here's a look at Novavax's past performance and the resulting price change:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -1.80 -3.91 -3.63 -3.60
EPS Actual -11.18 -4.31 -4.75 -3.05
Price Change % 0.44% -11.27% -19.61% -13.91%

Stock Performance

Shares of Novavax were trading at $58.66 as of May 05. Over the last 52-week period, shares are down 64.99%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

To track all earnings releases for Novavax visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

What is inkl?
The world’s most important news, from 100+ trusted global sources, in one place.
Morning Edition
Your daily
news overview

Morning Edition ensures you start your day well informed.

No paywalls, no clickbait, no ads
Enjoy beautiful reading

Content is only half the story. The world's best news experience is free from distraction: ad-free, clickbait-free, and beautifully designed.

Expert Curation
The news you need to know

Stories are ranked by proprietary algorithms based on importance and curated by real news journalists to ensure that you receive the most important stories as they break.